Back to Search Start Over

Adherence of Beta Thalssemia Patients to Oral Chelation Therapy.

Source :
Clinical Trials Week; 9/9/2024, p160-160, 1p
Publication Year :
2024

Abstract

The article focuses on a clinical trial evaluating adherence to oral chelation therapy in beta thalassemia patients. Topics include the prevalence and management of beta thalassemia; the use of different iron chelators (deferoxamine, deferiprone, deferasirox); and the impact of chelator administration routes and side effects on patient adherence.

Details

Language :
English
ISSN :
15436772
Database :
Complementary Index
Journal :
Clinical Trials Week
Publication Type :
Periodical
Accession number :
179479052